We describe a novel pharmacological activity of the gentian root, an ingredient of Chinese medicines. Root extract from Gentiana triflora triggered cell death of human Daudi cells in culture. In addition, daily administration of the extract to mice inhibited growth of implanted solid tumors. Extract treatment of cultured cells resulted in the appearance of shranken, fragmented, or condensed cell and nuclear morphologies, and in chromosomal DNA degradation. But, the extract-treated cells did not show DNA fragmentation, which exhibits a nucleosome ladder, suggesting that extracttriggered cell death is not mediated through a typical apoptotic pathway.
Plants belonging to Gentianaceae are widely used in traditional medicines in many countries. Among them, the roots of Gentiana scabra, Gentiana triflora, and Gentiana rigescens are used as ingredients in Chinese herbal medicines for stimulation of appetite and gastric secretion, gastro-duodenal protection, liver protection, antifungal treatment, and in some cases for women's diseases. Although scientific studies on these beneficial effects have not yet accumulated, recent reports have elucidated interesting biochemical and pharmacological activities of the root extract or components. For instance, an inhibitor(s) of aldose reductase, 1) an antagonist of platelet activating factor (PAF), 2) free radical scavenging activity, 3) and a hepatoprotective effect 4, 5) and smooth muscle relaxing activity 6) of gentiopicroside, a compound found present in many gentian species, have been reported. In the present study, we found a novel pharmacological activity of gentian root extract, viz., antiproliferative activity against tumor cells in culture and in vivo.
Roots of Gentiana triflora var. japonica were extracted in boiling water for 30 min, dried under vacuum, and dissolved in PBS. To examine antiproliferative activity, increasing amounts of the extract were added to human Daudi cells (Burkitt's lymphoma), which were pre-cultured for 12 h in DMEM supplemented with 10% fetal bovine serum. After culturing for an additional 24 h, the number of living cells was counted by Trypan blue exclusion assay. As shown in Fig. 1A , proliferation of the cells was inhibited in the presence of the extract, with an ED 50 of about 0.9 mg/ml. In addition, cells cultured for 24 h in the presence of the extract (1 mg/ml) did not re-initiate proliferation within 72 h after withdrawal of the extract (Fig. 1B) . Thus the root extract caused irreversible damage to the Daudi cells.
Then we examined whether the extract inhibits growth of tumor cells in vivo. For this purpose, Renca cells 7, 8) (murine renal cell carcinoma of spontaneous origin) was subcutaneously implanted into the backs of BALB/c mice (8-week-old male, CLEA Japan, Tokyo, Japan). To the tumor-implanted mice, the root extract in standard saline solution (0.2 ml) was orally administered in two ways. One group received the extract (330 mg/ kg, about 4 mg per mouse) daily starting from the day of implantation ( Fig. 2A) , and the other group from 7 d before implantation (Fig. 2B ). Control tumor-carrying mice received the standard saline solution without the extract. Proliferation of the implanted tumors was measured as the growth in the tumor volume, using the following calculation:
where a is the length of the major axis (mm) and b is the minor axis (mm) of the solid tumor. 9, 10) Both these experiments showed that once daily administration of the extract for about one month caused inhibition of the growth of the tumor by 30 to 40%, as compared to the control tumor-carrying mice (statistical comparisons were made according to Student's t-test, significance P < 0:05). These results indicate that the root extract inhibited proliferation of solid tumors in vivo after circulation via intestinal absorption. Although the antiproliferative factor that acted on cultured cells has been found to be a low-molecular-weight compound, it is not certain whether the same compound acted in vivo in the mice. This point ought to be elucidated in the future by animal experiments using purified antiproliferative factor. During the experimental period, the body weights of the mice were not significantly affected by the administration of the root extract (data not shown).
Next we investigated the mechanism that induced cell death. Figure 3A shows morphological changes seen in Daudi cells after culturing for 12 h with the extract (1 mg/ml). The extract-treated cells showed morphology of shranken or fragmented cells and nuclei. In addition, flow cytometric analysis using FITC-labeled Annexin V indicated inversion of plasma membrane in a population of extract-treated cells (data not shown). These morphological changes appeared to be events involved in apoptotic cell death. 11, 12) DNA degradation also occurred in the extract-treated cells (Fig. 3B) . In contrast to the apoptotic events, however, neither DNA fragmentation showing a so-called nucleosome ladder nor release of cytochrome C from the mitochondria into the cytoplasm was observed (data not shown). Therefore, at present, we think that the death of Daudi cells caused by the root extract differs from typical apoptosis.
Purification and structural analysis of the antiproliferative factor are now in progress. Preliminary experiments using the partially purified factor showed that susceptibility of cells to the factor differs among cell types. Human Daudi and mouse Y3-Ag1. susceptible. From these results, together with the fact that the root extract caused irreversible damage to a certain cell type (Fig. 1B) , the possibility arises that the antiproliferative factor binds irreversibly to a cell-typespecific surface receptor(s). The mechanism acting on such a cell-type-specific cytotoxicity is of great interest and remains to be elucidated. Animal experiments in this study were conducted in accordance with the ''Guidelines for Animal Experiments'' of Iwate Medical University, according to internationally accepted principles for laboratory animal use and care.
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